Dominant Negative MCP‐1 Blocks Human Osteoclast Differentiation
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Human osteoclasts were differentiated using receptor activator of NFκB ligand (RANKL) and macrophage colony stimulating factor (M‐CSF) from colony forming unit‐granulocyte macrophage (CFU‐GM) precursors of the myeloid lineage grown from umbilical cord blood. Gene expression profiling using quantitative polymerase chain reaction (Q‐PCR) showed more than 1,000‐fold induction of chemokine MCP‐1 within 24 h of RANKL treatment. MCP‐1 mRNA content exceeds that of other assayed chemokines (CCL1, 3, 4, and 5) at all time points up to day 14 of treatment. MCP‐1 induction preceded peak induction of calcium signaling activator calmodulin 1 (CALM1) and transcription factors JUN and FOS, which were at 3 days. Key osteoclast related transcription factors NFATc1 and NFATc2 showed peak induction at 7 days, while marker genes for osteoclast function cathepsin K and tartrate resistance acid phosphatase (TRAP) were maximally induced at 14 days, corresponding with mature osteoclast function. To test whether the early and substantial peak in MCP‐1 expression is part of human osteoclast differentiation events, a dominant negative inhibitor of MCP‐1 (7ND) was added simultaneously with RANKL and M‐CSF, resulting in blockade of CALM1, JUN and NFATc2 induction and strong inhibition of human osteoclast differentiation. These data show that a cascade of gene expression leading to osteoclast differentiation depends on intact early MCP‐1 induction and signaling in human osteoclasts. J. Cell. Biochem. 115: 303–312, 2014. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T. J., & Suda, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7260 · Cited by 1,048
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051150 · Cited by 849
The role of NFAT in osteoclast formation
TAKAYANAGI, H. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.071 · Cited by 442 · cited 1×
“Osteoclast differentiation is characterized by induction of transcription factors necessary for osteoclast differentiation including JUN, FOS, and NFATc1 [Takayanagi, 2007; Sitara and Aliprantis, 2010].”
BackgroundNICHOLSON, G. C., MALAKELLIS, M., COLLIER, F. M., CAMERON, P. U., HOLLOWAY, W. R., GOUGH, T. J., GREGORIO-KING, C., KIRKLAND, M. A., & MYERS, D. E. (2000) · Clinical Science · doi:10.1042/cs0990133 · Cited by 107
Self-citation
Cited by
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
Gschwandtner, M., Derler, R., & Midwood, K. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02759 · Cited by 611
Ehnert, S., Aspera-Werz, R. H., Ihle, C., Trost, M., Zirn, B., Flesch, I., Schröter, S., Relja, B., & Nussler, A. K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030406 · Cited by 45
Mallia, I., Fioravanti, A., & Guiducci, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110408 · Cited by 14
Bakr, M. M., Kelly, W. L., Brunt, A. R., Paterson, B. C., Massa, H. M., Morrison, N. A., & Forwood, M. R. (2020) · JBMR Plus · doi:10.1002/jbm4.10387 · Cited by 4
“This may be explained by the PTH induction of monocyte chemotactic protein-1, which is responsible for differentiation and recruitment of osteoclast precursors in early remodeling phases.((51,52)) The mechanism of the anabolic action of PTH is also supported by other factors, including calcium availability and the cal…”
BackgroundSelf-citation
Metadata
- Authors
- Morrison, N. A., Day, C. J., & Nicholson, G. C.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2013-12-13
- Volume
- 115
- Issue
- 2
- Pages
- 303-312
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1488864527
- Cited by
- 37
- References
- 4
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.